| Report Name | Report Type | Specialty | Publish Date | |
|---|---|---|---|---|
| Endovascular Coiling Market Assessment (United States) Wave 2 | Survey | Neuro | Nov 20, 2007 | PAID REPORT |
| To understand the current and future trends in the endovascular market, perceptions of various manufacturers and endovascular coils in the U.S. Additionally to: Understand the use of microcoil products Compare overall perceptions of various... | ||||
| Alzheimers disease: Current and Emerging Therapies | Discussion | Neuro | Oct 16, 2007 | PAID REPORT |
| Panel Intelligence engaged a panel of neurologists in a discussion designed to understand the current and emerging therapies that are used to treat Alzheimer�s disease (AD). In addition to this primary objective, the qualitative study aimed to: Understand current treatment... | ||||
| Radiosurgery and Radiotherapy Systems: US Market Assessment | Survey | Neuro, Oncology | Apr 29, 2007 | FREE |
| To understand current and future usage of radiosurgical systems, with a specific focus on the Accuray CyberKnife, by surveying a set of physicians and hospital administrators. Gauge awareness, perceptions and experience levels among physicians and hospital administrators with a... | ||||
| Treatment of Parkinson’s Disease and Movement Disorders | Discussion | Neuro | Oct 26, 2006 | FREE |
| Evaluate awareness, perception, and potential of rotigotine patch for Parkinson�s disease (PD) and Restless Leg Syndrome (RLS) Understand competitive advantages, threats, market impact of rotigotine Products Highlighted: Neupro� (rotigotine); Aderis Pharmaceuticals Mirapex�... | ||||
| European Markets Evaluation of Tysabri SEP 2006 | Survey | Neuro | Sep 19, 2006 | FREE |
| Identify current patient populations and treatments for multiple sclerosis (MS) Determine current and anticipated future use of Tysabri Distinguish the target population for Tysabri in both countries using Tysabri (Germany and the United Kingdom) and countries anticipating its future... | ||||
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |